Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 36 clinical trials
featured
  • 91 views
  • 23 Nov, 2020
  • 1 location
featured
Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes

We are seeking participants for a new clinical research study to evaluate the long term treatment effects of an investigational medication on diabetic retinopathy progression in adults with type 2 diabetes.  

hemoglobin a1c
diabetes type 2
type 2 diabetes mellitus
diabetes
type 2 diabetes
  • 72 views
  • 14 Jan, 2021
  • 1 location
featured
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in subjects with type 2 diabetes

A study to evaluate an FDA approved once daily oral diabetic medication with new dosages to potentially further improve blood sugar control and increase weight loss in patients with Type 2 Diabetes.

diabetes
diabetes type 2
type 2 diabetes
type 2 diabetes mellitus
  • 0 views
  • 09 Feb, 2021
  • 1 location
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease. Participants will either get semaglutide or placebo (a "dummy

  • 0 views
  • 01 Aug, 2021
  • 141 locations
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants

  • 0 views
  • 02 Aug, 2021
  • 257 locations
16-week Flexible vs. 8-week Semaglutide Titration

Semaglutide is a Glucagon Like Peptide 1 (GLP-1) receptor agonist recently approved in Israel to improve glycemic control in patients with type 2 diabetes mellitus. Semaglutide is currently

  • 0 views
  • 25 Jan, 2021
  • 1 location
Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology

Current anti-diabetic treatment fails to stop the progressive course of the disease. Recent studies have revealed a surprisingly high variability in the diabetic phenotype. The investigators propose that anti-diabetic treatment should ideally target the underlying pathophysiology of each individual patient. The investigators will therefore test whether the effect of two …

  • 0 views
  • 25 Jan, 2021
  • 1 location
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease. Participants will either get semaglutide or placebo (a "dummy

  • 0 views
  • 01 Aug, 2021
  • 122 locations
Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity

study. This is to compare the effect on heart failure symptoms and on body weight in people taking semaglutide (a new medicine) to people taking "dummy" medicine. Participants will either

body mass index
  • 0 views
  • 02 Aug, 2021
  • 70 locations
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

The researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. The

overweight or obesity
cardiovascular disease
body mass index
  • 7721 views
  • 18 Jul, 2021
  • 1165 locations